Comorbidities and mortality in bipolar disorder: a Swedish national cohort study.

By C. Crump, K. Sundquist, M. Winkleby, J. Sundquist. JAMA psychiatry, 2013

656 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Evidence-based guidelines for treating bipolar disorder: revised third edition Recommendations from the British Association for Psychopharmacology (2009, neutral): “This is 20 fold greater than population rates and translates into risks at long term follow-up between 3-6% (I, (Chesney et al., 2014; Crump et al., 2013), which are amongst the highest for any psychiatric disorder.”
Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder (2015, background): “the general population (1-3), corresponding to a 10-25 year shortened life expectancy (2-9).”
Risks of all‐cause and suicide mortality in mental disorders: a meta‐review (2014, background): “We identified a further 12 mortality estimates from the largest single studies for disorders where there were no systematic reviews (32-42) (Table 2).”